Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126703431 | 12670343 | 1 | I | 20160808 | 20160808 | 20160822 | 20160822 | EXP | TR-JUBILANT GENERICS LIMITED-1056560 | JUBILANT | JOURNAL: AM J CARDIOL?AUTHOR: APARCI M, DOGAN M, YALCIN M, ISILAK Z, BICAKCI B?TITLE: PROTON PUMP INHIBITORS SHOULD BE USED CAUTIOUSLY IN PATIENTS WITH ACUTE CORONARY SYNDROME?VOLUME: 117 YEAR: 2016 PAGES: S71 | 72.00 | YR | F | Y | 0.00000 | 20160822 | OT | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126703431 | 12670343 | 1 | PS | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | 90901 | ||||||||||||
| 126703431 | 12670343 | 2 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 126703431 | 12670343 | 3 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 0 | ||||||||||||
| 126703431 | 12670343 | 4 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126703431 | 12670343 | 5 | C | ENOXAPARIN SODIUM. | ENOXAPARIN SODIUM | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126703431 | 12670343 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126703431 | 12670343 | Anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |